<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Wednesday November 16th 2022 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2022-11-16" ></link>
<id>urn:uuid:5e234a1f-00da-a88b-8cc6-6c327b5eae49</id>
<updated>2026-06-13T10:43:43-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>AEHR: SCOTT GEOFFREY GATES (DIR) Sold (S) 15k Shares of AEHR TEST SYSTEMS for $25.21 on 11/15</title>
<link href="http://www.insiderinsights.com/company/aehr/aehr-test-systems/id-5648526" ></link>
<id>urn:uuid:f526ba55-ee81-2629-020f-4b1fc5851880</id>
<updated>2022-11-16T20:54:27-05:00</updated>
<summary type="html" ><![CDATA[AEHR TEST SYSTEMS (AEHR). Recent Price: $108.47. Mkt Cap:3.4B. 10D Vol: 2.0mm]]></summary>
</entry>
<entry>
<title>ALTR: SRIKANTH MAHALINGAM (CTO) Exercised 2k Options (OB) of ALTAIR ENGINEERING INC for $2.48 on 11/15, and Kept Them All</title>
<link href="http://www.insiderinsights.com/company/altr/altair-engineering-inc/id-5648524" ></link>
<id>urn:uuid:b73ca6b1-dc1f-1e1f-0327-531dfb2975c3</id>
<updated>2022-11-16T20:54:12-05:00</updated>
<summary type="html" ><![CDATA[ALTAIR ENGINEERING INC (ALTR)]]></summary>
</entry>
<entry>
<title>ARES: ROSENTHAL BENNETT (F,CB,DIR) Sold (AS) 200k Shares of ARES MANAGEMENT CORP for $78.84-$82.71 on 11/14</title>
<link href="http://www.insiderinsights.com/company/ares/ares-management-corp/id-5648505" ></link>
<id>urn:uuid:ffe1bf44-eebb-e876-262b-cd6e401cde4e</id>
<updated>2022-11-16T20:22:33-05:00</updated>
<summary type="html" ><![CDATA[ARES MANAGEMENT CORP (ARES). Recent Price: $134.90. Mkt Cap:44.5B. 10D Vol: 2.3mm]]></summary>
</entry>
<entry>
<title>ACRV: GAMELIN ERICK (O) Acquired (JB) 20,030 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 11/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-5648542" ></link>
<id>urn:uuid:97ab594a-25c6-9923-6866-29287cb1112d</id>
<updated>2022-11-16T19:21:49-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.48. Mkt Cap:63.3mm. 10D Vol: 342,500]]></summary>
</entry>
<entry>
<title>ACRV: DEVROE ERIC (COO) Acquired (JB) 33,383 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 11/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-5648541" ></link>
<id>urn:uuid:b52d33e8-0a48-e02e-b97f-7882efe798b6</id>
<updated>2022-11-16T19:18:09-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.48. Mkt Cap:63.3mm. 10D Vol: 342,500]]></summary>
</entry>
<entry>
<title>ACRV: HOLM JORGENSEN RASMUS (CFO) Acquired (JB) 20,030 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 11/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-5648540" ></link>
<id>urn:uuid:7efd06f5-f5b2-5f60-20d5-1e49c2c34782</id>
<updated>2022-11-16T19:13:18-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.48. Mkt Cap:63.3mm. 10D Vol: 342,500]]></summary>
</entry>
<entry>
<title>ACRV: MASSON KRISTINA (VP,DIR) Acquired (JB) 26,707 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 11/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-5648538" ></link>
<id>urn:uuid:0df098d5-a46a-9f19-4a4a-ee415e9eb049</id>
<updated>2022-11-16T19:10:43-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.48. Mkt Cap:63.3mm. 10D Vol: 342,500]]></summary>
</entry>
<entry>
<title>ACRV: MASSON KRISTINA (VP,DIR) Acquired (JB) 1.5mm Shares of ACRIVON THERAPEUTICS INC for $0.00 on 11/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-5648539" ></link>
<id>urn:uuid:de62670b-7b57-8655-fabe-a7729d068d68</id>
<updated>2022-11-16T19:10:43-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.48. Mkt Cap:63.3mm. 10D Vol: 342,500]]></summary>
</entry>
<entry>
<title>ACRV: BLUME JENSEN PETER (PR,CEO,DIR) Acquired (JB) 1.5mm Shares of ACRIVON THERAPEUTICS INC for $0.00 on 11/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-5648536" ></link>
<id>urn:uuid:def35c98-d0d0-5a9b-368d-da231e271664</id>
<updated>2022-11-16T19:05:47-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.48. Mkt Cap:63.3mm. 10D Vol: 342,500]]></summary>
</entry>
<entry>
<title>ACRV: BLUME JENSEN PETER (PR,CEO,DIR) Acquired (JB) 26,707 Shares of ACRIVON THERAPEUTICS INC for $0.00 on 11/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-5648537" ></link>
<id>urn:uuid:1753d93a-2fd7-3178-4ae9-ab3b43d48fa5</id>
<updated>2022-11-16T19:05:47-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.48. Mkt Cap:63.3mm. 10D Vol: 342,500]]></summary>
</entry>
</feed>